• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number VBH131002W
Device Problem Separation Failure (2547)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/01/2022
Event Type  malfunction  
Manufacturer Narrative
A review of the manufacturing records indicated the device met pre-release specifications.Imaging evaluation: three non-dicom/jpeg images submitted for evaluation.Image appears to depict vessel irregularity.Second image appears to demonstrate the use of a pta balloon.Third blurry image appears to demonstrate a deployed device.The image(s) received cannot be used to perform a full imaging evaluation due to insufficient data in relation to the reported event and/or poor quality of the image(s) provided.The device remains implanted and delivery catheter was discarded by hospital facility.Therefore, no engineering evaluation could be performed.Cause of the reported event cannot be established based on evaluation of the images and the information reported to gore.Further information regarding this event was requested by gore, but no further information has been reported, therefore this investigation is considered complete.Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following was reported to gore: on (b)(6) 2022, a patient was to be implanted with a 13mm x 10cm gore® viabahn® endoprosthesis with heparin bioactive surface (viabahn device) to treat brachiocephalic vein occlusion.The right brachiocephalic vein of the patient was stenosis.A cook 12 fr sheath was used to puncture from right cephalic vein, and a 55 cm sheath was used.A terumo 0.035¿¿ guidewire was inserted through right brachiocephalic vein to inferior vena cava.A 12mm x 80mm balloon was used to pre-dilate the target lesion and viabahn device was advanced to the target lesion.Physician initiated the deployment and viabahn device completed the fully expansion.But physician found that the deployment line couldn't be removed afterwards.Per dsa imaging, physician suspected that the deployment line stuck on the viabahn device near the middle portion of the device.In order to remove deployment line, physician tried to advance delivery catheter or to use a 12mm x 40mm balloon to dilate the viabahn, deployment line cannot be removed.Therefore, physician cut the deployment line and remove it.A deployment line fragment was stuck with the device and left in patient.Imaging showed the right brachiocephalic vein was patent.Patient tolerated the procedure.
 
Manufacturer Narrative
E1: update country from japan to china.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
qiong wang
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key13925461
MDR Text Key289080010
Report Number2017233-2022-02826
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/27/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/05/2024
Device Catalogue NumberVBH131002W
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/07/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/07/2021
Is the Device Single Use? Yes
Type of Device Usage A
Patient Sequence Number1
Patient Age69 YR
Patient SexMale
Patient Weight72 KG
-
-